-
Fresenius Kabi USA, LLC et al v. Custopharm, Inc. DC
- 1:18-cv-00665
- W.D. Tex.
- Judge: Lee Yeakel
- Filed: 08/06/2018
- Closed: 08/13/2019
- Latest Docket Entry: 08/13/2019
- PACER
- Docket updated daily
2
Plaintiffs
1
Defendant
2
Accused
Products
3
Patents-in-Suit
373
Days in
Litigation
-
Fresenius Kabi USA, LLC et al v. Custopharm, Inc. DC
- 1:18-cv-00665
- W.D. Tex.
- Judge: Lee Yeakel
- Filed: 08/06/2018
- Closed: 08/13/2019
- Latest Docket Entry: 08/13/2019
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
CUSTOpharm, Inc.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 2 mg ropivacaine hydrochloride per 1 mL formulation in 100 mL nfusion bags2 mg ropivacaine hydrochloride per 1 mL formulation in 200 mL nfusion bags | US 7,828,787 B2 | All Asserted Claims |
Infringement
Entry 61
|
| 2 mg ropivacaine hydrochloride per 1 mL formulation in 100 mL nfusion bags2 mg ropivacaine hydrochloride per 1 mL formulation in 200 mL nfusion bags | US 8,118,802 B2 | All Asserted Claims |
Infringement
Entry 61
|
| 2 mg ropivacaine hydrochloride per 1 mL formulation in 100 mL nfusion bags2 mg ropivacaine hydrochloride per 1 mL formulation in 200 mL nfusion bags | US 8,162,915 B2 | All Asserted Claims |
Infringement
Entry 61
|
